These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27343791)

  • 1. Oxytocin in cesarean-sections. What's new?
    Yamaguchi ET; Siaulys MM; Torres ML
    Braz J Anesthesiol; 2016; 66(4):402-7. PubMed ID: 27343791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oxytocin in cesarean-sections. What's new?].
    Yamaguchi ET; Siaulys MM; Torres ML
    Rev Bras Anestesiol; 2016; 66(4):402-7. PubMed ID: 26626317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a third stage of labor oxytocin protocol on cesarean delivery outcomes.
    Lee AI; Wong CA; Healy L; Toledo P
    Int J Obstet Anesth; 2014 Feb; 23(1):18-22. PubMed ID: 24332518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oxytocin for the prophylaxis of uterine atony after cesarean delivery. Should we reconsider our protocols?].
    Schiraldi R; Guasch E
    Rev Esp Anestesiol Reanim; 2014; 61(7):359-61. PubMed ID: 24924341
    [No Abstract]   [Full Text] [Related]  

  • 5. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
    Borruto F; Treisser A; Comparetto C
    Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery.
    George RB; McKeen D; Chaplin AC; McLeod L
    Can J Anaesth; 2010 Jun; 57(6):578-82. PubMed ID: 20238255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs of the use of carbetocin in the prevention of uterine atony following delivery of the infant by Caesarean section - retrospective multicenter study.
    Sobkowski M; Celewicz Z; Kalinka J; Szymanowski K; Serafin M; Śmieja K; Grzymała-Figura A; Pacocha K; Pieniążek I; Walczak J; Żyła A; Bierut A
    Ginekol Pol; 2016; 87(9):621-628. PubMed ID: 27723068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five unit bolus oxytocin at cesarean delivery in women at risk of atony: a randomized, double-blind, controlled trial.
    King KJ; Douglas MJ; Unger W; Wong A; King RA
    Anesth Analg; 2010 Dec; 111(6):1460-6. PubMed ID: 20889945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of carbetocin in prevention of uterine atony during cesarean section. Comparison with oxytocin].
    Triopon G; Goron A; Agenor J; Aya GA; Chaillou AL; Begler-Fonnier J; Bousquet PJ; Mares P
    Gynecol Obstet Fertil; 2010 Dec; 38(12):729-34. PubMed ID: 21111653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Median Effective Dose of Oxytocin Needed to Prevent Uterine Atony During Cesarean Delivery in Elderly Parturients.
    Wei CN; Deng JL; Dong JH; Ping ZP; Chen XZ
    Drug Des Devel Ther; 2020; 14():5451-5458. PubMed ID: 33335388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist.
    Dyer RA; Butwick AJ; Carvalho B
    Curr Opin Anaesthesiol; 2011 Jun; 24(3):255-61. PubMed ID: 21415725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of uterotonic drugs during caesarean section.
    Dyer RA; van Dyk D; Dresner A
    Int J Obstet Anesth; 2010 Jul; 19(3):313-9. PubMed ID: 20627531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ergometrine given during caesarean section and incidence of delayed postpartum haemorrhage due to uterine atony.
    Lourens R; Paterson-Brown S
    J Obstet Gynaecol; 2007 Nov; 27(8):795-7. PubMed ID: 18097896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight-based versus fixed dose oxytocin infusion for preventing uterine atony during cesarean section in laboring patients: A randomized trial.
    Tyagi A; Bodh P; Mohta M; Gupta B
    Int J Gynaecol Obstet; 2024 Mar; 164(3):985-991. PubMed ID: 37715535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of clinical risk-prediction models for uterine atony following vaginal and cesarean delivery.
    Ende HB; French B; Shi Y; Kertai MD; Osmundson SS; Bauchat JR
    Int J Obstet Anesth; 2022 Aug; 51():103550. PubMed ID: 35550835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss.
    Chaudhuri P; Banerjee GB; Mandal A
    Int J Gynaecol Obstet; 2010 Apr; 109(1):25-9. PubMed ID: 20070961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight-based oxytocin infusion for preventing uterine atony during caesarean delivery in non-labouring patients: A dose-response study.
    Tyagi S; Tyagi A; Rashmi S; Mohta M; Gupta B
    Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):497-503. PubMed ID: 36846888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section.
    Boucher M; Horbay GL; Griffin P; Deschamps Y; Desjardins C; Schulz M; Wassenaar W
    J Perinatol; 1998; 18(3):202-7. PubMed ID: 9659650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postpartum hemorrhage in the developed world: whither misoprostol?
    Gibbins KJ; Albright CM; Rouse DJ
    Am J Obstet Gynecol; 2013 Mar; 208(3):181-3. PubMed ID: 22901709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial.
    Munn MB; Owen J; Vincent R; Wakefield M; Chestnut DH; Hauth JC
    Obstet Gynecol; 2001 Sep; 98(3):386-90. PubMed ID: 11530117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.